Mankind Pharma informs about disclosure

01 Mar 2025 Evaluate
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mankind Pharma has informed that the Company has received an Order on 28 February 2025 issued by Deputy Commissioner -State Tax, Nagpur under Section 73 of the CGST Act, 2017. The detailed disclosure as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/ PoD2/CIR/P/0155 dated November 11, 2024 as amended from time to time for aforesaid is enclosed as annexure I. 

The above information is a part of company’s filings submitted to BSE.

Mankind Pharma Share Price

2551.65 -51.15 (-1.97%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...